FDA Inspection 1200814 — Tesla Biohealing, Inc.

Tesla Biohealing, Inc. — FEI 3023229437

The FDA completed an inspection of Tesla Biohealing, Inc. on Mar 23, 2023 in Milford, DE. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 4 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Mar 23, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Milford, DE (United States)

Citations

IDCFRDescription
319221 CFR 820.30(g)Design validation - user needs and intended uses
323221 CFR 820.72(a)Equipment suitability & capability
342521 CFR 820.50(a)(1)Evaluation and Selection, Suppliers, Contractors, etc.
41921 CFR 820.20(b)Lack of or inadequate organizational structure

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.